OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) IN PATIENTS WITH MYELOFIBROSIS (MF) EXPOSED TO JAK1/2 INHIBITORS

被引：0

作者：

Shanavas, M. ^{[1
]}

Popat, U. ^{[2
]}

Michaelis, L. C. ^{[3
]}

Fauble, V. ^{[4
]}

Mclornan, D. ^{[5
]}

Klisovic, R. ^{[6
]}

Mascarenhas, J. ^{[7
]}

Tamari, R. ^{[8
]}

Arcasoy, M. ^{[9
]}

Davies, J. ^{[10
]}

Gergis, U. ^{[11
]}

Ukaegbu, O. ^{[12
]}

Kamble, R. ^{[13
,14
]}

Storring, J. ^{[15
]}

Majhail, N. S. ^{[16
]}

Romee, R. ^{[17
]}

Lew, J. ^{[7
]}

Pagliuca, A. ^{[5
]}

Vasu, S. ^{[6
]}

Ernst, B. ^{[4
]}

Atenafu, E. ^{[1
]}

Hanif, A. ^{[3
]}

Champlin, R. ^{[2
]}

Hari, P. ^{[2
]}

Gupta, V. ^{[1
]}

机构：

[1] Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[4] Mayo Clin Arizona, Rochester, MN USA

[5] Kings Coll London, London, England

[6] Ohio State Univ, Columbus, OH 43210 USA

[7] Mt Sinai Med Ctr, New York, NY 10029 USA

[8] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[9] Duke Univ, Sch Med, Durham, NC 27706 USA

[10] Oxford Univ Hosp NHS Trust, Churchill Hosp, Oxford, England

[11] Weill Cornell Med Coll, New York, NY USA

[12] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[13] Baylor Coll Med, Houston, TX 77030 USA

[14] Houston Methodist Hosp, Houston, TX USA

[15] McGill Univ, Ctr Hlth, Montreal, PQ, Canada

[16] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA

[17] Washington Univ, Sch Med, St Louis, MO USA

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

S450

引用

页码：162 / 163

页数：2

共 50 条

[31] Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis
Bewersdorf, Jan Philipp
Sheth, Amar H.
Vetsa, Shaurey
Grimshaw, Alyssa
Giri, Smith
Podoltsev, Nikolai A.
Gowda, Lohith
Tamari, Roni
Tallman, Martin S.
Rampal, Raajit K.
Zeidan, Amer M.
Stahl, Maximilian
TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (10): : 873.e1 - 873.e13
[32] Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Tania Jain
Katie L. Kunze
Luke Mountjoy
Daniel K. Partain
Heidi Kosiorek
Nandita Khera
William J. Hogan
Vivek Roy
James L. Slack
Pierre Noel
Veena D. S. Fauble
Jose F. Leis
Lisa Sproat
Ayalew Tefferi
Mrinal M. Patnaik
Ruben A. Mesa
Jeanne Palmer
Blood Cancer Journal, 10
[33] Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Jain, Tania
Kunze, Katie L.
Mountjoy, Luke
Partain, Daniel K.
Kosiorek, Heidi
Khera, Nandita
Hogan, William J.
Roy, Vivek
Slack, James L.
Noel, Pierre
Fauble, Veena D. S.
Leis, Jose F.
Sproat, Lisa
Tefferi, Ayalew
Patnaik, Mrinal M.
Mesa, Ruben A.
Palmer, Jeanne
BLOOD CANCER JOURNAL, 2020, 10 (03)
[34] Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
Hamilton, Betty Ky
Rybicki, Lisa
Gerds, Aaron
Hanna, Rabi
Sobecks, Ronald
Hien Duong
Starn, Jamie
Corbett, Elaina
Bolwell, Brian
Majhail, Navneet S.
Kalaycio, Matt E.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S226 - S227
[35] Mitochondrial Haplotype As an Independent Predictor of Outcomes Following Allogeneic Hematopoietic Cell Transplantation (HCT)
Ross, Julie A.
Tolar, Jakub
Spector, Logan G.
Defor, Todd E.
Lund, Troy C.
Weisdorf, Daniel J.
Hooten, Anthony J.
Thyagarajan, Bharat
Langer, Erica
Gleason, Michelle K.
Wagner, John E.
Robien, Kimberly
Verneris, Michael R.
BLOOD, 2014, 124 (21)
[36] Serum Autoantibodies in Allogeneic Hematopoietic Cell Transplantation (HCT) Patients: A Pilot Study
Pasic, Ivan
Di Meo, Ashley
Prassas, Ioannis
Batruch, Ihor
Wilson, Leeann
Diamandis, Eleftherios P.
Michelis, Fotios V.
BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 339 - 339
[37] PERCEIVED COGNITION AMONG PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)
Cessna, Julie
Jim, Heather
Nelson, Ashley M.
Jacobsen, Paul
Sutton, Steven
O'Brian, Olivia
ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S115 - S115
[38] Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
Murthy, Guru Subramanian Guru
Kim, Soyoung
Estrada-Merly, Noel
Abid, Muhammad Bilal
Aljurf, Mahmoud
Assal, Amer
Badar, Talha
Badawy, Sherif M.
Ballen, Karen
Beitinjaneh, Amer
Cerny, Jan
Chhabra, Saurabh
DeFilipp, Zachariah
Dholaria, Bhagirathbhai
Perez, MiguelAngel Diaz
Farhan, Shatha
Freytes, Cesar O.
Gale, Robert Peter
Ganguly, Siddhartha
Gupta, Vikas
Grunwald, Michael R.
Hamad, Nada
Hildebrandt, Gerhard C.
Inamoto, Yoshihiro
Jain, Tania
Jamy, Omer
Juckett, Mark
Kalaycio, Matt
Krem, Maxwell M.
Lazarus, Hillard M.
Litzow, Mark
Munker, Reinhold
Murthy, Hemant S.
Nathan, Sunita
Nishihori, Taiga
Orti, Guillermo
Patel, Sagar S.
van der Poel, Marjolein
Rizzieri, David A.
Savani, Bipin N.
Seo, Sachiko
Solh, Melhem
Verdonck, Leo F.
Wirk, Baldeep
Yared, Jean A.
Nakamura, Ryotaro
Oran, Betul
Scott, Bart
Saber, Wael
HAEMATOLOGICA, 2023, 108 (07) : 1900 - 1908
[39] Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis
Cyriac, Sunu
Prem, Shruti
Salas, Maria Queralt
Chen, Shiyi
Al-Shaibani, Zeyad
Lam, Wilson
Law, Arjun
Gupta, Vikas
Michelis, Fotios V.
Kim, Dennis
Lipton, Jeffrey
Kumar, Rajat
Mattsson, Jonas
Viswabandya, Auro
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (05) : 517 - 528
[40] Impact of Mixed Chimerism on Myelofibrosis Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation
Srour, Samer A.
Popat, Uday R.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (12) : E301 - E302

← 1 2 3 4 5 →